AI & EducationAI & HealthcareBusiness & DecisionInnovation & AI

Let’s Talk AI – March 8, 2024

In this week’s “Let’s Talk AI” (Week 10), dive into the world of Claude 3, the latest version of the chatbot developed by the American startup Anthropic, which reportedly outperforms GPT-4 and Google Gemini 1.0 in numerous tests. Also, learn the details of the planned rollout in France by the end of 2024 of a tool using artificial intelligence in all en-route air traffic control centers (CRNA). Finally, explore the opportunities AI offers the retail sector by boosting sales and improving customer satisfaction.

www.usinenouvelle.com

www.energyvoice.com

www.lsa-conso.fr

Don’t miss our upcoming articles!

Get the latest articles written by aivancity experts and professors delivered straight to your inbox.

We don’t send spam! Please see our privacy policy for more information.

Don’t miss our upcoming articles!

Get the latest articles written by aivancity experts and professors delivered straight to your inbox.

We don’t send spam! Please see our privacy policy for more information.

Related posts
AI & HealthcareAI Research

MAGIC: How the Global Assessment Is Changing Generative AI in Healthcare

Published on October 6, 2026 in Nature Medicine, the founding paper of MAGIC announces an international network designed to develop a more representative evaluation of generative AI in healthcare. Its goal is to move beyond…
AI & EducationEthics & Safety

Student Safety: What Microsoft's New AI Standard Entails

Microsoft, theAmerican Federation of Teachers and theUnited Federation of Teachers have established a Standard Contractual Clauses on Security and Confidentiality for the use of artificial intelligence in schools at United States. Starting on November 1,…
AI & Healthcare

Pink October 2026: what AI really changes in breast cancer screening

In 2026, several clinical studies evaluated artificial intelligence in breast cancer screening, going beyond retrospective testing alone. The randomized MASAI trial reports fewer cancers detected between two screening rounds, while other studies show possible gains…